Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Revista De Psiquiatria Y Salud Mental|December 3, 2014
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample descriptionLaura Pina-Camacho, Covadonga M Díaz-Caneja, Pilar A Saiz, et al.
Psychological Medicine|September 9, 2020
The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychosesSilvia Amoretti, Adriane R Rosa, Gisela Mezquida, et al.
Schizophrenia Research|May 20, 2022
The network structure of cognitive deficits in first episode psychosis patientsAna M Sánchez-Torres, Victor Peralta, Gustavo J Gil-Berrozpe, et al.
Ebiomedicine|January 14, 2020
Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trialIluminada Corripio, Alexandra Roldán, Salvador Sarró, et al.
Revista De Psiquiatria Y Salud Mental|July 15, 2022
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosisElisa Rodríguez-Toscano, Kenia Martínez, David Fraguas, et al.
Schizophrenia Research|March 7, 2017
Gene-environment interaction as a predictor of early adjustment in first episode psychosisDavid Fraguas, Covadonga M Díaz-Caneja, Iluminada Corripio, et al.
The International Journal of Neuropsychopharmacology|October 29, 2015
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs ProjectMiquel Bioque, Adrián Llerena, Bibiana Cabrera, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Pageof 10